Related Experiment Video
Updated: Jul 19, 2026

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation
Keiichi Akaiwa1, Hidetoshi Akashi, Hideki Harada
1Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
Insights
Cerebral venous congestion (VC) before stroke significantly reduced brain infarct size and neurological deficits in rats. Mild VC provided neuroprotection, while severe VC increased mortality, suggesting a therapeutic window for adenosine A1 receptor activation.
Area of Science:
- Neuroscience
- Cardiovascular Surgery
- Cerebrovascular Research
Background:
- Stroke is a major complication in cardiovascular surgery, often exacerbated by increased intracranial pressure due to cerebral venous circulatory disturbances (CVCD).
- Previous research indicated that inducing CVCD before cerebral ischemia could decrease infarct area.
Purpose of the Study:
- To investigate the neuroprotective effects of pre-ischemic cerebral venous congestion (VC) in a rat model of focal cerebral ischemia.
- To evaluate the role of adenosine A1 receptor activation in mediating this protective effect.
Main Methods:
- Focal cerebral ischemia was induced in spontaneously hypertensive rats using filament insertion.
- Rats were assigned to sham-operated, mild VC, severe VC, or DPCPX (adenosine A1 receptor antagonist) groups.
- Evaluated infarct volume, cerebral edema, S-100 protein levels, and behavioral deficits.
Main Results:
- Mild and severe VC groups exhibited significantly reduced infarct volumes compared to sham and DPCPX groups.
- Mild VC significantly decreased edema and neurological deficits compared to other groups.
- Severe VC led to a time-dependent increase in mortality.
- DPCPX administration abolished the protective effects of mild VC.
Conclusions:
- Appropriate pre-ischemic cerebral venous congestion can rapidly induce cerebral protection, likely mediated by adenosine A1 receptor activation.
- Mild VC demonstrates neuroprotective potential, reducing infarct size, edema, and neurological deficits.
- The findings suggest a potential therapeutic strategy for stroke prevention or treatment by modulating cerebral venous pressure.
Abstract:
Stroke is a devastating complication in cardiovascular surgery, and neuronal damage is worsened by intracranial pressure elevation caused by cerebral venous circulatory disturbances (CVCD). However, we have previously reported that CVCD before cerebral ischemia decreases the infarct area. In the present study, focal cerebral ischemia was induced in spontaneously hypertensive rats by filament insertion through the carotid artery. Rats were divided into the following four groups: sham-operated, mild or severe venous congestion (VC), and DPCPX. The DPCPX group received the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) prior to mild VC. Behavior, infarct volume, edema and S-100 protein were evaluated among the four groups. The infarct volume rates in mild VC and severe VC groups were significantly less than that in sham-operated and DPCPX groups. However, the mortality of the severe VC group worsened in a time-dependent manner. We observed a significant decrease in edema in the mild VC group compared to the DPCPX group. Behavioral scores also indicated that the mild VC group had fewer neurological deficits than the other three groups, including the DPCPX group. We were able to induce rapid cerebral protection via adenosine A1 receptor activation by administering an appropriate degree of VC prior to cerebral ischemia produced by middle cerebral artery occlusion. Our work suggests possible mechanisms by which such effective VC may lead to cerebral protection and adenosine A1 receptor activation.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction
Cytotoxic Edema: Pathophysiology
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Ischemic Stroke ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology